CELLULAR ENHANCEMENTS IN BIOLOGICAL SYSTEMS THROUGH THE USE OF LI-POFULLERENE AND PEPTIDE GROUP COMBINATIONS
    9.
    发明申请
    CELLULAR ENHANCEMENTS IN BIOLOGICAL SYSTEMS THROUGH THE USE OF LI-POFULLERENE AND PEPTIDE GROUP COMBINATIONS 有权
    通过使用LI-POFULLERENE和肽组合的生物系统中的细胞增殖

    公开(公告)号:US20150258181A1

    公开(公告)日:2015-09-17

    申请号:US14656304

    申请日:2015-03-12

    申请人: LivePet, LLC

    摘要: In some embodiments, a chemical composition may include C60, serrapeptase, or a tetrapeptide. The tetrapeptide may include ALA,GLU,ASP,GLY. In some embodiments, the chemical composition may include a dipeptide. The dipeptide may include carnosine or camatine. In some embodiments, the chemical composition may include at least one lipid. One or more components of the chemical composition may be suspended in and/or dissolved in the at least one lipid. At least one lipid may include olive oil or mussel oil. In some embodiments, a method may include administering to a subject an effective amount of a pharmaceutically acceptable formulation comprising the chemical composition. The method may include inhibiting and/or ameliorating inflammation and/or a malady associated with inflammation. In some embodiments, the subject may include a human or a nonhuman mammal. Nonhuman mammals may include equines, canines, or felines.

    摘要翻译: 在一些实施方案中,化学组合物可包括C60,锯齿酶解酶或四肽。 四肽可以包括ALA,GLU,ASP,GLY。 在一些实施方案中,化学组合物可以包括二肽。 二肽可以包括肌肽或卡马汀。 在一些实施方案中,化学组合物可以包括至少一种脂质。 化学组合物的一种或多种组分可以悬浮在和/或溶解于至少一种脂质中。 至少一种脂质可以包括橄榄油或贻贝油。 在一些实施方案中,方法可以包括向受试者施用有效量的包含化学组成的药学上可接受的制剂。 该方法可以包括抑制和/或改善炎症和/或与炎症相关的疾病。 在一些实施方案中,受试者可以包括人或非人类哺乳动物。 非人类哺乳动物可能包括马,犬或猫科动物。